DK3847157T3 - Fremgangsmåde til fremstilling af methyl-[6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat] og salt deraf - Google Patents
Fremgangsmåde til fremstilling af methyl-[6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat] og salt deraf Download PDFInfo
- Publication number
- DK3847157T3 DK3847157T3 DK19765711.7T DK19765711T DK3847157T3 DK 3847157 T3 DK3847157 T3 DK 3847157T3 DK 19765711 T DK19765711 T DK 19765711T DK 3847157 T3 DK3847157 T3 DK 3847157T3
- Authority
- DK
- Denmark
- Prior art keywords
- fluorpropyl
- dichlorphenyl
- annulene
- oxyphenyl
- pyrrolidin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
- B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
- B01J31/1616—Coordination complexes, e.g. organometallic complexes, immobilised on an inorganic support, e.g. ship-in-a-bottle type catalysts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/06—Oxalic acid
- C07C55/07—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Health & Medical Sciences (AREA)
- Pyrrole Compounds (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306177 | 2018-09-07 | ||
| PCT/EP2019/073827 WO2020049153A1 (en) | 2018-09-07 | 2019-09-06 | Process for the preparation of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3847157T3 true DK3847157T3 (da) | 2022-08-08 |
Family
ID=63637829
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19765710.9T DK3847156T3 (da) | 2018-09-07 | 2019-09-06 | Salte af methyl-6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat og fremgangsmåde til fremstilling deraf |
| DK19765711.7T DK3847157T3 (da) | 2018-09-07 | 2019-09-06 | Fremgangsmåde til fremstilling af methyl-[6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat] og salt deraf |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19765710.9T DK3847156T3 (da) | 2018-09-07 | 2019-09-06 | Salte af methyl-6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat og fremgangsmåde til fremstilling deraf |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20210188771A1 (da) |
| EP (2) | EP3847157B1 (da) |
| JP (2) | JP7398436B2 (da) |
| KR (2) | KR20210057032A (da) |
| CN (2) | CN112638869A (da) |
| AR (2) | AR116300A1 (da) |
| AU (2) | AU2019335542A1 (da) |
| BR (2) | BR112021003061A2 (da) |
| CA (2) | CA3111466A1 (da) |
| DK (2) | DK3847156T3 (da) |
| ES (2) | ES2923412T3 (da) |
| HU (2) | HUE059362T2 (da) |
| IL (2) | IL281191B (da) |
| MX (2) | MX2021002666A (da) |
| SG (2) | SG11202102059YA (da) |
| TW (2) | TWI803692B (da) |
| WO (2) | WO2020049150A1 (da) |
| ZA (2) | ZA202101006B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3434272A1 (en) | 2017-07-25 | 2019-01-30 | Sanofi | Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
| AR116300A1 (es) * | 2018-09-07 | 2021-04-21 | Sanofi Sa | Proceso para la preparación de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilato de metilo |
| AU2020399168A1 (en) | 2019-12-09 | 2022-07-28 | Sanofi | Crystalline form of a 7H-benzo[7]annulene-2-carboxylic acid derivative |
| CN115916769B (zh) | 2020-06-28 | 2024-09-10 | 深圳扬厉医药技术有限公司 | 并环吲唑类化合物 |
| JP2023546899A (ja) | 2020-10-19 | 2023-11-08 | サノフイ | 置換６，７－ジヒドロ－５ｈ－ベンゾ［７］アヌレン化合物およびそれらの誘導体、それらの製造のための方法ならびにそれらの治療的使用 |
| JP2023545552A (ja) | 2020-10-19 | 2023-10-30 | サノフイ | 置換６，７－ジヒドロ－５ｈ－ベンゾ［７］アヌレン化合物およびそれらの誘導体、それらの製造のための方法ならびにそれらの治療的使用 |
| WO2023125700A1 (zh) | 2021-12-28 | 2023-07-06 | 南京明德新药研发有限公司 | 四氢环庚吲唑化合物的盐型、晶型 |
| WO2023187086A1 (en) | 2022-03-31 | 2023-10-05 | Sanofi | Amorphous solid form of amcenestrant |
| WO2023198903A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted fluorinated n-propyl-pyrrolidine and n‑propyl-azetidine compounds, processes for their preparation and therapeutic uses thereof |
| WO2023198904A1 (en) * | 2022-04-15 | 2023-10-19 | Sanofi | Substituted 6,7-dihydro-5h-benzo[7]annulene derivatives, processes for their preparation and therapeutic uses thereof |
| WO2023198901A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted 4-amino-4-oxo-but-2-enyl derivatives, processes for their preparation and therapeutic uses thereof |
| WO2023198879A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted fluorinated n-propyl-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof |
| WO2023198905A1 (en) | 2022-04-15 | 2023-10-19 | Sanofi | Novel substituted fluorinated vinyl-n-propyl-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1752792A (en) | 1991-03-08 | 1992-10-06 | Rhone-Poulenc Rorer International (Holdings) Inc. | Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| DE19833786A1 (de) | 1998-07-18 | 2000-01-20 | Schering Ag | Benzocycloheptene, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| ES2236056T3 (es) | 2001-01-24 | 2005-07-16 | Chiesi Farmaceutici S.P.A. | Derivados de 2h-1-benzopirano, procedimientos para su preparacion y composiciones farmaceuticas de los mismos. |
| EP1417169A2 (en) | 2001-08-11 | 2004-05-12 | Bristol-Myers Squibb Pharma Company | Selective estrogen receptor modulators |
| JP4554219B2 (ja) | 2002-04-24 | 2010-09-29 | メルク・シャープ・エンド・ドーム・コーポレイション | エストロゲン受容体調節剤 |
| AU2003292625B2 (en) | 2002-12-26 | 2008-07-24 | Eisai R & D Management Co., Ltd. | Selective estrogen receptor modulators |
| NZ552173A (en) | 2004-06-25 | 2010-07-30 | Janssen Pharmaceutica Nv | Quaternary salt CCR2 antagonists |
| WO2006138427A2 (en) | 2005-06-14 | 2006-12-28 | Baylor University | Combretastatin analogs with tubulin binding activity |
| US8127618B1 (en) | 2007-05-18 | 2012-03-06 | Pacesetter, Inc. | Implantable micro-electromechanical system sensor |
| EP2048126A1 (de) | 2007-10-11 | 2009-04-15 | Bayer Schering Pharma AG | Benzocycloheptanderivate als selektiv wirksame Estrogene |
| WO2009101634A2 (en) | 2008-02-13 | 2009-08-20 | Lupin Limited | A novel process for the preparation of eszopiclone |
| DE102010030538A1 (de) | 2010-06-25 | 2011-12-29 | Bayer Schering Pharma Aktiengesellschaft | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| GB2483736B (en) | 2010-09-16 | 2012-08-29 | Aragon Pharmaceuticals Inc | Estrogen receptor modulators and uses thereof |
| US20120130129A1 (en) | 2010-11-16 | 2012-05-24 | Baylor University | Efficient Method for Preparing Functionalized Benzosuberenes |
| CA2819299A1 (en) | 2010-12-24 | 2012-06-28 | Merck Sharp & Dohme B.V. | N-substituted azetidine derivatives |
| DE102011087987A1 (de) | 2011-12-08 | 2013-06-13 | Bayer Intellectual Property Gmbh | 6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln |
| CN105658628A (zh) | 2011-12-30 | 2016-06-08 | 北京赛林泰医药技术有限公司 | 新型芳基乙烯衍生物及其在选择性雌激素受体调节剂中的应用 |
| CN102584687A (zh) | 2011-12-30 | 2012-07-18 | 北京赛林泰医药技术有限公司 | 作为选择性雌激素受体调节剂的乙烯衍生物 |
| LT3033086T (lt) | 2013-08-14 | 2021-12-27 | Novartis Ag | Kombinuota terapija vėžiui gydyti |
| WO2015028409A1 (de) | 2013-08-27 | 2015-03-05 | Bayer Pharma Aktiengesellschaft | 6,7-dihydro-5h-benzo[7]annulen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
| WO2015082990A1 (en) | 2013-12-06 | 2015-06-11 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulator for the treatment of locally advanced or metastatic estrogen receptor positive breast cancer |
| JP6807841B2 (ja) | 2014-12-18 | 2021-01-06 | エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト | エストロゲン受容体モジュレーター及びその使用 |
| BR112017007662B1 (pt) | 2014-12-18 | 2021-11-03 | F. Hoffmann-La Roche Ag | Composto, composição farmacêutica e uso de um composto |
| RU2737496C2 (ru) | 2015-04-29 | 2020-12-01 | Радиус Фармасьютикалз, Инк. | Способы лечения рака |
| CN106924210A (zh) | 2015-12-29 | 2017-07-07 | 北京新领先医药科技发展有限公司 | 一种含有帕布昔利布的胶囊剂及其制备方法 |
| SG11201806829TA (en) * | 2016-02-15 | 2018-09-27 | Sanofi Sa | 6,7-dihydro-5h-benzo[7]annulene derivatives as estrogen receptor modulators |
| RU2742278C2 (ru) | 2016-11-17 | 2021-02-04 | Санофи | Новые соединения замещенного n-(3-фторпропил)пирролидина, способы их получения и их терапевтическое применение |
| EP3434272A1 (en) | 2017-07-25 | 2019-01-30 | Sanofi | Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid |
| AR116300A1 (es) * | 2018-09-07 | 2021-04-21 | Sanofi Sa | Proceso para la preparación de 6-(2,4-diclorofenil)-5-[4-[(3s)-1-(3-fluoropropil)pirrolidin-3-il]oxifenil]-8,9-dihidro-7h-benzo[7]anuleno-2-carboxilato de metilo |
| SG11202104923YA (en) | 2018-11-16 | 2021-06-29 | Arqule Inc | Pharmaceutical combination for treatment of cancer |
| WO2020225375A1 (en) | 2019-05-09 | 2020-11-12 | Sanofi | 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid for use in metastatic or advanced breast cancer patients |
| CN114302879A (zh) * | 2019-07-22 | 2022-04-08 | 太阳医药高级研究有限公司 | 选择性雌激素受体降解剂 |
| CN114945570A (zh) * | 2019-11-04 | 2022-08-26 | 里科瑞尔姆Ip控股有限责任公司 | 雌激素受体调节剂的盐和形式 |
| AU2020399168A1 (en) * | 2019-12-09 | 2022-07-28 | Sanofi | Crystalline form of a 7H-benzo[7]annulene-2-carboxylic acid derivative |
-
2019
- 2019-09-06 AR ARP190102550A patent/AR116300A1/es unknown
- 2019-09-06 CA CA3111466A patent/CA3111466A1/en active Pending
- 2019-09-06 KR KR1020217006752A patent/KR20210057032A/ko active Search and Examination
- 2019-09-06 AU AU2019335542A patent/AU2019335542A1/en active Pending
- 2019-09-06 TW TW108132201A patent/TWI803692B/zh active
- 2019-09-06 AU AU2019336532A patent/AU2019336532A1/en active Pending
- 2019-09-06 HU HUE19765710A patent/HUE059362T2/hu unknown
- 2019-09-06 DK DK19765710.9T patent/DK3847156T3/da active
- 2019-09-06 BR BR112021003061-1A patent/BR112021003061A2/pt not_active IP Right Cessation
- 2019-09-06 ES ES19765710T patent/ES2923412T3/es active Active
- 2019-09-06 MX MX2021002666A patent/MX2021002666A/es unknown
- 2019-09-06 EP EP19765711.7A patent/EP3847157B1/en active Active
- 2019-09-06 DK DK19765711.7T patent/DK3847157T3/da active
- 2019-09-06 CN CN201980058342.XA patent/CN112638869A/zh active Pending
- 2019-09-06 MX MX2021002665A patent/MX2021002665A/es unknown
- 2019-09-06 TW TW108132203A patent/TW202026280A/zh unknown
- 2019-09-06 SG SG11202102059YA patent/SG11202102059YA/en unknown
- 2019-09-06 CN CN201980058412.1A patent/CN112638870A/zh active Pending
- 2019-09-06 HU HUE19765711A patent/HUE059527T2/hu unknown
- 2019-09-06 JP JP2021512678A patent/JP7398436B2/ja active Active
- 2019-09-06 KR KR1020217006751A patent/KR20210057031A/ko active Search and Examination
- 2019-09-06 EP EP19765710.9A patent/EP3847156B1/en active Active
- 2019-09-06 ES ES19765711T patent/ES2924738T3/es active Active
- 2019-09-06 JP JP2021512672A patent/JP7413363B2/ja active Active
- 2019-09-06 CA CA3111359A patent/CA3111359A1/en active Pending
- 2019-09-06 SG SG11202102057SA patent/SG11202102057SA/en unknown
- 2019-09-06 IL IL281191A patent/IL281191B/en unknown
- 2019-09-06 WO PCT/EP2019/073823 patent/WO2020049150A1/en unknown
- 2019-09-06 BR BR112021003440-4A patent/BR112021003440A2/pt not_active IP Right Cessation
- 2019-09-06 AR ARP190102549A patent/AR116299A1/es unknown
- 2019-09-06 WO PCT/EP2019/073827 patent/WO2020049153A1/en unknown
-
2021
- 2021-02-15 ZA ZA2021/01006A patent/ZA202101006B/en unknown
- 2021-02-17 ZA ZA2021/01079A patent/ZA202101079B/en unknown
- 2021-03-02 IL IL281196A patent/IL281196B2/en unknown
- 2021-03-05 US US17/193,706 patent/US20210188771A1/en active Pending
- 2021-03-05 US US17/193,776 patent/US11713296B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3847157T3 (da) | Fremgangsmåde til fremstilling af methyl-[6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylat] og salt deraf | |
| DK3658147T3 (da) | Kombination, som omfatter palbociclib og 6-(2,4-dichlorphenyl)-5-[4-[(3s)-1-(3-fluorpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulen-2-carboxylsyre, og dens anvendelse til behandling af cancer | |
| EP3287445A4 (en) | Pyrazolone compound or salt thereof, preparation method therefor, herbicide composition and use thereof | |
| EP3398938A4 (en) | PYRAZOL COMPOUND OR SALT AND MANUFACTURING METHOD, HERBICIDAL COMPOSITION AND USE THEREOF | |
| DK3340981T3 (da) | Aryl, heteroaryl og heterocykliske forbindelser til behandling af medicinske forstyrrelser | |
| DK3724191T3 (da) | 5-(2-(2,5-difluorphenyl)pyrrolidin-1-yl)-3-(1h-pyrazol-1-yl)pyrazol[1,5-a]pyrimidinderivater og lignende forbindelser som trk-kinasehæmmere til cancerbehandling | |
| PL3252046T3 (pl) | Skondensowany związek heterocykliczny z grupą cykloalkilopirydylową lub jej solą, środek owadobójczy stosowany w rolnictwie i ogrodnictwie zawierający ten związek oraz sposób stosowania tego środka owadobójczego | |
| EA201790290A1 (ru) | Формерные соли (2s,3s)-метил 7-фтор-2-(4-фторфенил)-3-(1-метил-1h-1,2,4-триазол-5-ил)-4-оксо-1,2,3,4-тетрагидрохинолин-5-карбоксилата и способы их получения | |
| DK3421475T3 (da) | Kondenseret heterocyklisk forbindelse med bundne heterocyklusser og salte deraf, landbrugs-/havebrugsinsekticid indeholdende nævnte forbindelse og fremgangsmåde til anvendelse af nævnte insekticid | |
| DK3357922T3 (da) | 2-((5-(1-(3-(methylsulfonyl)propyl)piperidin-4-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8h)-on-derivater og relaterede forbindelser som cdk4-inhibitorer til behandling af tumorer | |
| EP4174056A4 (en) | ARYL TETRAHYDROPYRIDINE DERIVATIVE OR SALT THEREOF, INSECTICIDE CONTAINING IT AND METHOD OF USE THEREOF | |
| DK3275883T3 (da) | Fremgangsmåde til produktion af ny nitrogenholdig forbindelse eller salt deraf, og mellemprodukt deraf | |
| DK3412671T3 (da) | TLR7-agonist-maleatsalt, krystallinske former C, D og E deraf, fremgangsmåder til fremstilling og anvendelser af maleatsalt og krystallinske former | |
| EP3483162A4 (en) | FUSED N-ALKYLSULFONYL HETEROCYCLIC COMPOUND OR SALTS THEREOF, PESTICIDE CONTAINING SAID COMPOUND AND METHOD OF USING SAID PESTICIDE | |
| DK3717476T3 (da) | Fremgangsmåde til fremstilling af 2-(5-methoxyisochroman-1-yl)-4,5-dihydro-1H-imidazol og hydrogensulfatsaltet deraf | |
| EP3293178A4 (en) | Pyrazole compound or salt thereof, and preparation method, herbicide composition and use thereof | |
| ZA201907272B (en) | N-(4-pyridyl)nicotinamide compound or salt thereof | |
| EP3608312A4 (en) | SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, THEIR PREPARATION PROCESS, PHARMACEUTICAL COMPOSITION AND RELATED APPLICATIONS | |
| EP4046686A4 (en) | SALT TYPES, CRYSTALLINE FORMS AND METHODS FOR PREPARING BENZOPYRAZOLE COMPOUNDS USED AS RHO KINASE INHIBITORS | |
| DK3725781T3 (da) | Krystal og salt af 4-(naphthalen-1-yl)-4H-1,2,4-triazol-forbindelse og fremgangsmåde til fremstilling deraf | |
| DK3655395T3 (da) | Fremgangsmåde til fremstilling af n-((1r,2s,sr)-5-(tert-butylamino)-2-((s)-3-(7- tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1- yl)cyclohexyl)acetamid | |
| EA201892261A1 (ru) | Гетероциклические амиды, пригодные в качестве модуляторов белков | |
| EP3967683A4 (en) | SUBSTITUTED FLUORINE-CONTAINING IMIDAZOLE SALT COMPOUND, METHOD OF PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | |
| TH1501000645A (th) | เกลือและรูปของแข็งของ(s)-3-(4-((4-มอร์ฟอลิโนเมธิล)เบนซิล)ออกซิ)-1-ออกโซไอโซอินโดลิน-2-อิล)ไพเพอริดีน-2,6-ไดโอน และองค์ประกอบซึ่งประกอบรวมด้วย และวิธีของการใช้สารเดียวกัน |